鹽酸帕羅西汀雜質(zhì)Ⅱ(N-甲基帕羅西汀)
|
PCL-#-Chp0328-25mg
|
≥95% 雜質(zhì)對照品 |
110429-36-2 |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸帕羅西汀雜質(zhì)Ⅰ(去氟帕羅西?。?
|
PCL-#-Chp0327-50mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0327-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸帕羅西汀雜質(zhì)Ⅰ(去氟帕羅西汀)
|
PCL-#-Chp0327-25mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0327-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸昂丹司瓊雜質(zhì)D?
|
PCL-#-Chp0326-50mg
|
≥95% ,雜質(zhì)對照品 |
99614-64-9 |
50mg
|
¥ 600.0
|
3-5天 |
PCL |
鹽酸昂丹司瓊雜質(zhì)D (9-甲基-3-亞甲基-2,3-二氫-1H-咔唑-4(9H)-酮)
|
PCL-#-Chp0326-25mg
|
≥95% 雜質(zhì)對照品 |
99614-64-9 |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸環(huán)丙沙星雜質(zhì)Ⅵ雜質(zhì)I 1-環(huán)丙基-7-氯-6-[(2-氨乙基)氨基]-4-氧代-1,4-二氫喹啉-3-羧酸;環(huán)丙沙星雜質(zhì)Ⅵ(環(huán)丙沙星雜質(zhì) I)
|
PCL-#-Chp0325-50mg
|
≥95%,雜質(zhì)對照品 |
528851-30-1 |
50mg
|
¥ 9200.0
|
1-2周 |
PCL |
鹽酸環(huán)丙沙星雜質(zhì)Ⅵ雜質(zhì)I 1-環(huán)丙基-7-氯-6-[(2-氨乙基)氨基]-4-氧代-1,4-二氫喹啉-3-羧酸;環(huán)丙沙星雜質(zhì)Ⅵ(環(huán)丙沙星雜質(zhì) I)
|
PCL-#-Chp0325-25mg
|
≥95% 雜質(zhì)對照品 |
528851-30-1 |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸環(huán)丙沙星雜質(zhì)Ⅴ雜質(zhì)E1-環(huán)丙基-6-氟-7-(哌嗪1-基)喹啉-4-(1H)酮
|
PCL-#-Chp0324-50mg
|
≥95% 雜質(zhì)對照品 |
105394-83-0 |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸環(huán)丙沙星雜質(zhì)Ⅴ雜質(zhì)E1-環(huán)丙基-6-氟-7-(哌嗪1-基)喹啉-4-(1H)酮
|
PCL-#-Chp0324-25mg
|
≥95% 雜質(zhì)對照品 |
105394-83-0 |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸環(huán)丙沙星雜質(zhì)Ⅲ雜質(zhì)C7-[(2-氨乙基)氨基]-1-環(huán)丙基-6-氟-4-氧代-1,4-二氫喹啉-3-羧酸
|
PCL-#-Chp0322-50mg
|
≥95% 雜質(zhì)對照品 |
528851-31-2 |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸環(huán)丙沙星雜質(zhì)Ⅲ雜質(zhì)C7-[(2-氨乙基)氨基]-1-環(huán)丙基-6-氟-4-氧代-1,4-二氫喹啉-3-羧酸
|
PCL-#-Chp0322-25mg
|
≥95% 雜質(zhì)對照品 |
528851-31-2 |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸環(huán)丙沙星雜質(zhì)Ⅱ雜質(zhì)B1-環(huán)丙基-4-氧代-7-(1-哌嗪基)-1,4-二氫喹啉-3-羧酸
|
PCL-#-Chp0321-50mg
|
≥95% 雜質(zhì)對照品 |
93107-11-0 |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸環(huán)丙沙星雜質(zhì)Ⅱ雜質(zhì)B1-環(huán)丙基-4-氧代-7-(1-哌嗪基)-1,4-二氫喹啉-3-羧酸
|
PCL-#-Chp0321-25mg
|
≥95% 雜質(zhì)對照品 |
93107-11-0 |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸環(huán)丙沙星雜質(zhì)Ⅰ雜質(zhì)A 7-氯-1-環(huán)丙基-6-氟-4-氧代-1,4-二氫喹啉-3-羧酸
|
PCL-#-Chp0320-50mg
|
≥95% 雜質(zhì)對照品 |
86393-33-1 |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸環(huán)丙沙星雜質(zhì)Ⅰ雜質(zhì)A 7-氯-1-環(huán)丙基-6-氟-4-氧代-1,4-二氫喹啉-3-羧酸
|
PCL-#-Chp0320-25mg
|
≥95% 雜質(zhì)對照品 |
86393-33-1 |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸納洛酮雜質(zhì)Ⅱ(2,2‘-雙納洛酮)
|
PCL-#-Chp0319-50mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0319-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸納洛酮雜質(zhì)Ⅱ(2,2‘-雙納洛酮)
|
PCL-#-Chp0319-25mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0319-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸納洛酮雜質(zhì)Ⅰ(-)-4,5α-環(huán)氧基-3,14-二羥基嗎啡喃-6-酮
|
PCL-#-Di045-50mg
|
≥95% 雜質(zhì)對照品 |
33522-95-1 |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸納洛酮雜質(zhì)Ⅰ(-)-4,5α-環(huán)氧基-3,14-二羥基嗎啡喃-6-酮
|
PCL-#-Di045-25mg
|
≥95% 雜質(zhì)對照品 |
33522-95-1 |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸納美芬雜質(zhì)Ⅱ(雙納美芬)2,2`-雙納美芬
|
PCL-#-Chp0318-50mg
|
≥95% 雜質(zhì)對照品 |
176220-84-1 |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸納美芬雜質(zhì)Ⅱ(雙納美芬)2,2`-雙納美芬
|
PCL-#-Chp0318-25mg
|
≥95% 雜質(zhì)對照品 |
176220-84-1 |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸納美芬雜質(zhì)
|
PCL-#-Chp0317-50mg
|
≥95%,雜質(zhì)對照品 |
16676-29-2 |
50mg
|
¥ 4000.0
|
現(xiàn)貨 |
PCL |
鹽酸納美芬雜質(zhì)Ⅰ(鹽酸納曲酮)17-環(huán)丙基甲基-4,5-環(huán)氧-3,14-二羥基嗎啡喃-6-酮鹽酸鹽
|
PCL-#-Chp0317-25mg
|
≥95%,雜質(zhì)對照品 |
16676-29-2 |
25mg
|
咨詢
|
現(xiàn)貨 |
PCL |
鹽酸阿米洛利雜質(zhì)Ⅰ 3,5-二氨基-6-氯吡嗪-2-羧酸甲酯
|
PCL-#-Chp0316-50mg
|
≥95% 雜質(zhì)對照品 |
1458-01-1 |
50mg
|
咨詢
|
咨詢 |
PCL |